Medicskin Holdings Limited (HKG:8307)
Hong Kong · Delayed Price · Currency is HKD 0.1180
+0.0050 (4.42%)
Jul 10, 2026, 6:15 PM HKT
Medicskin Holdings Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 47.87 | 45.11 | 49.14 | 45.54 | 49.15 |
Other Revenue | 0.35 | 0.84 | 0.75 | 0.48 | 0.04 |
| 48.22 | 45.95 | 49.89 | 46.02 | 49.19 | |
Revenue Growth | 4.94% | -7.89% | 8.41% | -6.44% | 17.91% |
Cost of Revenue | 31.88 | 32.41 | 34.37 | 32.03 | 27.55 |
Gross Profit | 16.34 | 13.54 | 15.52 | 13.99 | 21.63 |
Selling, General & Admin | 0.03 | 0.03 | 0.05 | 0.21 | 0.06 |
Other Operating Expenses | 8.48 | 8.16 | 8.95 | 7.38 | 8.17 |
Operating Expenses | 15.68 | 17.25 | 18.39 | 16.92 | 17.96 |
Operating Income | 0.66 | -3.71 | -2.87 | -2.93 | 3.68 |
Interest Expense | -0.9 | -0.69 | -0.51 | -0.78 | -0.4 |
Interest & Investment Income | 0.76 | 1.01 | 0.66 | 0.52 | 0.45 |
Currency Exchange Gain (Loss) | 0.01 | -0.1 | -0.41 | -1.38 | 0.54 |
Other Non Operating Income (Expenses) | -0.01 | 0.05 | - | - | 0.03 |
EBT Excluding Unusual Items | 0.52 | -3.44 | -3.13 | -4.57 | 4.3 |
Gain (Loss) on Sale of Investments | -0.2 | - | 0.02 | 0.06 | 0.13 |
Gain (Loss) on Sale of Assets | 0.61 | - | - | - | - |
Asset Writedown | -0.01 | -0.02 | -0.01 | -0.02 | -0 |
Other Unusual Items | - | - | - | 0.83 | - |
Pretax Income | 0.92 | -3.46 | -3.12 | -3.7 | 4.42 |
Income Tax Expense | -0.01 | -0.08 | -0.02 | -0.11 | 0.28 |
Earnings From Continuing Operations | 0.94 | -3.38 | -3.1 | -3.59 | 4.14 |
Minority Interest in Earnings | - | 0.01 | 0.05 | 0.05 | -0.22 |
Net Income | 0.94 | -3.38 | -3.05 | -3.54 | 3.92 |
Net Income to Common | 0.94 | -3.38 | -3.05 | -3.54 | 3.92 |
Net Income Growth | - | - | - | - | 311.54% |
Shares Outstanding (Basic) | 397 | 397 | 397 | 397 | 397 |
Shares Outstanding (Diluted) | 397 | 397 | 397 | 397 | 397 |
Shares Change | - | - | - | - | -5.81% |
EPS (Basic) | 0.00 | -0.01 | -0.01 | -0.01 | 0.01 |
EPS (Diluted) | 0.00 | -0.01 | -0.01 | -0.01 | 0.01 |
EPS Growth | - | - | - | - | 337.00% |
Free Cash Flow | 4.25 | 8.29 | 9.12 | 0.95 | 1.93 |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.02 | 0.00 | 0.01 |
Gross Margin | 33.88% | 29.47% | 31.10% | 30.39% | 43.98% |
Operating Margin | 1.37% | -8.07% | -5.75% | -6.37% | 7.47% |
Profit Margin | 1.94% | -7.35% | -6.11% | -7.69% | 7.97% |
Free Cash Flow Margin | 8.80% | 18.04% | 18.28% | 2.06% | 3.92% |
EBITDA | 2.5 | -1.85 | -0.76 | -0.71 | 5.84 |
EBITDA Margin | 5.18% | -4.01% | -1.53% | -1.55% | 11.88% |
D&A For EBITDA | 1.84 | 1.87 | 2.11 | 2.22 | 2.17 |
EBIT | 0.66 | -3.71 | -2.87 | -2.93 | 3.68 |
EBIT Margin | 1.37% | -8.07% | -5.75% | -6.37% | 7.47% |
Effective Tax Rate | - | - | - | - | 6.24% |